Dr Vasanthakumar Ramu, VP & Head R&D – Peptides & Complex APIs, Alembic Pharma

hanuman

Active member
EP_VPS_Oct_2024_05_Dr_VK_Ramu_750.jpg





In this video:
Dr Vasanthakumar Ramu, VP & Head R&D – Peptides & Complex APIs, Alembic Pharma

Key Takeaway:
A Quality by Design (QbD) approach for peptide synthesis might involve studying impact of reaction temperature, catalyst concentration, and reaction time on product yield and purity to optimise process conditions. It helps in understanding CQAs of peptide API and manufacturing process

The post appeared first on .
 
Top
AdBlock Detected

We get it, advertisements are annoying!

Sure, ad-blocking software does a great job at blocking ads, but it also blocks useful features of our website. For the best site experience please disable your AdBlocker.

I've Disabled AdBlock